Axinn Adds Three Seasoned Antitrust Litigators, Reinforcing Trial Bench and West Coast Presence
Hires Position Firm to Meet Rising Client Demand as Antitrust Enforcement Intensifies
Axinn Appoints Rachael Philbin as Chief Innovation Officer
Appointment Reflects Firm’s Vision for the Future of Legal Practice
Axinn Wins Firm of the Year – Americas at 2026 Global Competition Review Awards
Axinn is proud to announce that it was named GCR “Firm of the Year – Americas,” recognizing an exceptional year defined by the quality and impact of the firm’s antitrust work. This is the fourth time the firm has won this award, reflecting Axinn’s continued growth, deep bench of talent, and success guiding clients through complex, high-stakes competition matters.
Axinn Partners John Harkrider and Craig Minerva Win 2026 Concurrences Antitrust Writing Award
John Harkrider and Craig Minerva won a 2026 Concurrences Antitrust Writing Award for their article “Antitrust in a Time of Trade War.” The article was recognized in the Business, Cross-Border category.
Axinn Associates at the Antitrust Spring Meeting
The Spring Meeting is the largest gathering of competition, consumer protection, and data privacy professionals globally, with lawyers, academics, economists, enforcers, journalists, and students from around the world. During the Spring Meeting, Axinn associates attended thought leadership panels to capture key insights.
Axinn Adds Three Seasoned Antitrust Litigators, Reinforcing Trial Bench and West Coast Presence
Hires Position Firm to Meet Rising Client Demand as Antitrust Enforcement Intensifies
Axinn Appoints Rachael Philbin as Chief Innovation Officer
Appointment Reflects Firm’s Vision for the Future of Legal Practice
Axinn Wins Firm of the Year – Americas at 2026 Global Competition Review Awards
Axinn is proud to announce that it was named GCR “Firm of the Year – Americas,” recognizing an exceptional year defined by the quality and impact of the firm’s antitrust work. This is the fourth time the firm has won this award, reflecting Axinn’s continued growth, deep bench of talent, and success guiding clients through complex, high-stakes competition matters.
Axinn Partners John Harkrider and Craig Minerva Win 2026 Concurrences Antitrust Writing Award
John Harkrider and Craig Minerva won a 2026 Concurrences Antitrust Writing Award for their article “Antitrust in a Time of Trade War.” The article was recognized in the Business, Cross-Border category.
Axinn Associates at the Antitrust Spring Meeting
The Spring Meeting is the largest gathering of competition, consumer protection, and data privacy professionals globally, with lawyers, academics, economists, enforcers, journalists, and students from around the world. During the Spring Meeting, Axinn associates attended thought leadership panels to capture key insights.
Axinn Adds Three Seasoned Antitrust Litigators, Reinforcing Trial Bench and West Coast Presence
Hires Position Firm to Meet Rising Client Demand as Antitrust Enforcement Intensifies
Our People
Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
Featured Insights
Featured Insights
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Informa CompLaw Antitrust West Coast Conference 2026
Speaking Engagement
Antitrust
2026 FDLI Annual Conference
Speaking Engagement
Intellectual Property
Let's Talk "About". . . That Bird?
Axinn Viewpoints
Intellectual Property
What’s on Antitrust Enforcers’ Minds? Federal and State Enforcer Perspectives on Health Care Transactions
Axinn Viewpoints
Antitrust
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property











